| dbo:abstract |
سوبي (بالإنجليزية: Sobi)، والاسم الكامل هو: سويدش أورفان بايوفيتروم (بالإنجليزية: Swedish Orphan Biovitrum AB (publ)) هي شركة عالمية مختصة بالرعاية الصحية ومكرسة للأمراض النادرة ومقرها في ستوكهولم في السويد. (ar) Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden. In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. (en) Swedish Orphan Biovitrum (Sobi) är ett läkemedelsföretag med två fokusområden: hemofili och sällsynta sjukdomar. (sv) |
| dbo:industry |
dbr:Pharmaceutical_company |
| dbo:keyPerson |
dbr:Guido_Oelkers |
| dbo:location |
dbr:Stockholm |
| dbo:numberOfEmployees |
1509 (xsd:nonNegativeInteger) |
| dbo:parentCompany |
dbr:Investor_AB |
| dbo:product |
dbr:Immunology |
| dbo:revenue |
1.5261E10 |
| dbo:revenueYear |
2020-01-01 (xsd:gYear) |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Karolinska_Institutet_Science_Park.jpg?width=300 |
| dbo:type |
dbr:Public_company |
| dbo:wikiPageExternalLink |
http://www.sobi.com/ |
| dbo:wikiPageID |
18046104 (xsd:integer) |
| dbo:wikiPageLength |
8268 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1110300943 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbc:Pharmaceutical_companies_of_Sweden dbr:Pfizer dbr:Pharmaceutical_company dbr:Pharmacia dbr:Respiratory_syncytial_virus dbr:Gamifant dbr:Kabivitrum dbr:Public_company dbr:Gout dbr:Synagis dbr:Stockholm dbr:Paroxysmal_nocturnal_hemoglobinuria dbc:2006_initial_public_offerings dbr:ALS dbr:Alprolix dbr:Essity dbr:Nordic_Capital dbr:Chronic_liver_disease dbr:Biogen_Idec dbr:Doptelet dbr:Haematology dbr:Haemophilia dbr:Hemophagocytic_lymphohistiocytosis dbr:Investor_AB dbc:Companies_listed_on_Nasdaq_Stockholm dbc:Companies_related_to_the_Wallenberg_family dbc:Pharmaceutical_companies_established_in_2001 dbr:Biopharmaceutical dbc:Swedish_companies_established_in_2001 dbc:Manufacturing_companies_based_in_Stockholm dbr:Elocta dbr:Metabolic_diseases dbr:Immunology dbr:Wyeth dbr:Immune_thrombocytopenic_purpura dbr:Octapharma dbr:Kineret_(medication) dbr:Orphan_drugs dbr:Guido_Oelkers dbr:Biovitrum dbr:Hemophilia |
| dbp:homepage |
http://www.sobi.com/ |
| dbp:industry |
dbr:Pharmaceutical_company |
| dbp:keyPeople |
dbr:Guido_Oelkers |
| dbp:location |
Stockholm, Sweden (en) |
| dbp:name |
Swedish Orphan Biovitrum AB (en) |
| dbp:numEmployees |
1509 (xsd:integer) |
| dbp:parent |
dbr:Investor_AB |
| dbp:products |
Treatments in the areas of haematology, immunology and specialty care (en) |
| dbp:revenue |
1.5261E10 |
| dbp:revenueYear |
2020 (xsd:integer) |
| dbp:type |
dbr:Public_company |
| dbp:wikiPageUsesTemplate |
dbt:! dbt:Authority_control dbt:Ill dbt:Infobox_company dbt:More_citations_needed_section dbt:Reflist dbt:Short_description dbt:Third-party dbt:OMX |
| dcterms:subject |
dbc:Pharmaceutical_companies_of_Sweden dbc:2006_initial_public_offerings dbc:Companies_listed_on_Nasdaq_Stockholm dbc:Companies_related_to_the_Wallenberg_family dbc:Pharmaceutical_companies_established_in_2001 dbc:Swedish_companies_established_in_2001 dbc:Manufacturing_companies_based_in_Stockholm |
| gold:hypernym |
dbr:Company |
| schema:sameAs |
http://viaf.org/viaf/194786406 |
| rdf:type |
owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 yago:WikicatCompaniesRelatedToTheWallenbergFamily yago:Abstraction100002137 yago:Company108058098 yago:DrugCompany108002578 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Organisation yago:SocialGroup107950920 yago:WikicatPharmaceuticalCompaniesOfSweden |
| rdfs:comment |
سوبي (بالإنجليزية: Sobi)، والاسم الكامل هو: سويدش أورفان بايوفيتروم (بالإنجليزية: Swedish Orphan Biovitrum AB (publ)) هي شركة عالمية مختصة بالرعاية الصحية ومكرسة للأمراض النادرة ومقرها في ستوكهولم في السويد. (ar) Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden. In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. (en) Swedish Orphan Biovitrum (Sobi) är ett läkemedelsföretag med två fokusområden: hemofili och sällsynta sjukdomar. (sv) |
| rdfs:label |
سويدش أورفان بايوفيتروم (ar) Swedish Orphan Biovitrum (en) スウェディッシュ・オーファン・バイオビトラム (ja) Swedish Orphan Biovitrum (sv) |
| owl:sameAs |
freebase:Swedish Orphan Biovitrum yago-res:Swedish Orphan Biovitrum wikidata:Swedish Orphan Biovitrum dbpedia-ar:Swedish Orphan Biovitrum http://arz.dbpedia.org/resource/سويدش_اورفان_بايوفيتروم dbpedia-fa:Swedish Orphan Biovitrum dbpedia-ja:Swedish Orphan Biovitrum dbpedia-sv:Swedish Orphan Biovitrum https://global.dbpedia.org/id/4vYaY http://viaf.org/viaf/194786406 |
| skos:closeMatch |
http://www.grid.ac/institutes/grid.420059.a http://www.grid.ac/institutes/grid.476779.c |
| prov:wasDerivedFrom |
wikipedia-en:Swedish_Orphan_Biovitrum?oldid=1110300943&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/Karolinska_Institutet_Science_Park.jpg |
| foaf:homepage |
http://www.sobi.com/ |
| foaf:isPrimaryTopicOf |
wikipedia-en:Swedish_Orphan_Biovitrum |
| foaf:name |
Swedish Orphan Biovitrum AB (en) |
| is dbo:subsidiary of |
dbr:Investor_AB |
| is dbo:wikiPageRedirects of |
dbr:Sobi dbr:Biovitrum |
| is dbo:wikiPageWikiLink of |
dbr:List_of_companies_of_Sweden dbr:List_of_drugs_granted_breakthrough_therapy_designation dbr:Verband_Forschender_Arzneimittelhersteller dbr:List_of_pharmaceutical_companies dbr:Collagenase_clostridium_histolyticum dbr:Wallenberg_family dbr:Amgen dbr:Anakinra dbr:Ancestim dbr:Nitisinone dbr:Investor_AB dbr:Sobi dbr:Biovitrum |
| is foaf:primaryTopic of |
wikipedia-en:Swedish_Orphan_Biovitrum |
